Darae Ko, MD, MSc

Publications

• Published 2/1/2026

  Li B, Gershengorn HB, Vail EA, Wunsch H, Walkey AJ, Law AC, Ko D, Ayalon N, Kearney CM, Bosch NA. Inotrope selection in mixed cardiogenic shock with sepsis: a comparative analysis between milrinone and dobutamine. Ann Am Thorac Soc. 2026 Feb 01; 23(2):252-260. PMID: 40960311.

  Read at: PubMed

• Published 11/18/2025

  Lo SW, Ko D, Kim DH, Ngo LH, Singer DE, Shah SJ. Apixaban Benefit in Subclinical Atrial Fibrillation Accounting for Competing Risks: A Reanalysis of the ARTESIA Trial. medRxiv. 2025 Nov 18. PMID: 41040706.

  Read at: PubMed

• Published 10/17/2025

  Luo L, Parks AL, Oh G, Berry SD, Mitchell SL, Kim DH, Shah SJ, Ko D. Patterns of Oral Anticoagulant Use in Atrial Fibrillation Following Transition to Long-Term Care. J Am Geriatr Soc. 2026 Jan; 74(1):265-268. PMID: 41103145.

  Read at: PubMed

• Published 8/27/2025

  Kim DH, Ko D, Singer DE, Cervone A, Zhang Y, Chen Q, Lin KJ. Clinical Outcomes of Switching From Warfarin to Apixaban or Rivaroxaban in Patients With Atrial Fibrillation: A Nationwide Multidatabase Study. Circ Cardiovasc Qual Outcomes. 2025 Sep; 18(9):e011890. PMID: 40859837.

  Read at: PubMed

• Published 6/23/2025

  Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, Commodore-Mensah Y, Currie ME, Elkind MSV, Fan W, Generoso G, Barone Gibbs B, Heard DG, Hiremath S, Johansen MC, Kazi DS, Ko D, Leppert MH, Magnani JW, Michos ED, Mussolino ME, Parikh NI, Perman SM, Rezk-Hanna M, Roth GA, Shah NS, Springer MV, St-Onge MP, Thacker EL, Urbut SM, Van Spall HGC, Voeks JH, Whelton SP, Wong ND, Wong SS, Yaffe K, Palaniappan LP. Correction to: 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2025 Jun 24; 151(25):e1096. PMID: 40549850.

  Read at: PubMed

View All 76 Publications:   View Full Profile in BUMC